Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia

Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Study ID
NCT00180960
Phase
PHASE2
Status
Terminated

Conditions

  • Appendix Tumors
  • Colon Tumors
  • Endocrine Tumors
  • Peritoneum Tumors
  • Rectum Tumors

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to evaluate the treatment of a cancerous disease of the peritoneum with complete cytoreductive surgery with intraperitoneal chemohyperthermia using oxaliplatin plus irinotecan. This is a Phase II study with 100 patients. Origins of the tumors: these include colon, rectum, appendix, peritoneum, and endocrine tumors.

Key Dates

First listed
Sep 16, 2005
Start date
Jun 30, 2003
Status verified
Sep 2006

Study Design

Enrollment
100 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

To study overall survival

Related Studies